Emerging Chemodynamic Nanotherapeutics for Cancer Treatment
Advanced Healthcare Materials · 2024-09 · 13 (22)
DOI: 10.1002/adhm.202400809 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, online erschienen am 23.05.2024. Verfasst von Dongqi Sun und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, P. R. China. Hauptthemen laut MEDLINE: Neoplasms, Tumor Microenvironment, Nanomedicine. Die Arbeit wurde bisher 97-mal zitiert (Crossref) und nennt 249 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Liaoning Province.
Abstract (Originalsprache)
Chemodynamic therapy (CDT) has emerged as a transformative paradigm in the realm of reactive oxygen species ‐mediated cancer therapies, exhibiting its potential as a sophisticated strategy for precise and effective tumor treatment. CDT primarily relies on metal ions and hydrogen peroxide to initiate Fenton or Fenton‐like reactions, generating cytotoxic hydroxyl radicals. Its notable advantages in cancer treatment are demonstrated, including tumor specificity, autonomy from external triggers, and a favorable side‐effect profile. Recent advancements in nanomedicine are devoted to enhancing CDT, promising a comprehensive optimization of CDT efficacy. This review systematically elucidates cutting‐edge achievements in chemodynamic nanotherapeutics, exploring strategies for enhanced Fenton or Fenton‐like reactions, improved tumor microenvironment modulation, and precise regulation in energy metabolism. Moreover, a detailed analysis of diverse CDT‐mediated combination therapies is provided. Finally, the review concludes with a comprehensive discussion of the prospects and intrinsic challenges to the application of chemodynamic nanotherapeutics in the domain of cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, 110016, P. R. China.
- Department of Pharmacy, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, 121001, China.
ORCID-Profile: Shenwu Zhang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Liaoning Province
Zitieren
APA
Sun, D., Sun, X., Zhang, X., Wu, J., Shi, X., Sun, J., Luo, C., He, Z., & Zhang, S. (2024). Emerging Chemodynamic Nanotherapeutics for Cancer Treatment. Advanced Healthcare Materials, 13(22). https://doi.org/10.1002/adhm.202400809
Vancouver
Sun D, Sun X, Zhang X, Wu J, Shi X, Sun J, et al. Emerging Chemodynamic Nanotherapeutics for Cancer Treatment. Advanced Healthcare Materials. 2024;13(22). doi:10.1002/adhm.202400809
BibTeX
@article{Sun2024,
author = {Sun, Dongqi and Sun, Xinxin and Zhang, Xuan and Wu, Jiaping and Shi, Xianbao and Sun, Jin and Luo, Cong and He, Zhonggui and Zhang, Shenwu},
title = {Emerging Chemodynamic Nanotherapeutics for Cancer Treatment},
journal = {Advanced Healthcare Materials},
year = {2024},
volume = {13},
number = {22},
doi = {10.1002/adhm.202400809}
}
EUVIMED